Barclays downgraded Lanxess to Equal Weight from Overweight with a price target of EUR 36, down from EUR 62. Expectations of “higher resilience has not played out” and lower bromine prices are likely to impede the company’s 2024 earnings recovery, the analyst tells investors in a research note.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on LNXSF:
